Dallas, November 6 (Reuters) / PRNewswire / —— Zimmer Biomet Holdings, Inc. (New York Stock Exchange and Swiss Stock Exchange ticker: ZBH) Today, we will announce “Surgeon - Guided Autonomy (Surgeon-Guided Autonomy)”, a new category of technology that represents the company's vision for the next generation of intelligent orthopedic surgeries.

For the complete multi-channel interactive press release, please visit: https :// www.multivu.com / zimmer /9427151- en-zimmer-biomet-introduces-surgeon-guided-autonomy-new-category-intelligent-surgery

This concept is based on a simple principle: to transfer the burden from surgeons, rather than control. Zimmer Biomet indicates that "surgeon-guided autonomy" envisions an intelligent system that can transform the surgeon-defined intentions into actions at various stages of the surgical plan, execution, and rehabilitation, while retaining the surgeon's professional knowledge, judgment, and control.

This concept will be officially introduced at the thematic seminar sponsored by Zimmer Biomet.The Future Is Now — From Kinematic Alignment to Intelligent Surgery, the event will take place at the annual meeting of the American Association of Hip and Knee Surgeons ( AAHKS ). The seminar will discuss unmet needs in the field of orthopedics, share the application of integrated kinematic alignment concepts in practice, and introduce “ Surgeon - Guided Autonomy ” and its new framework:Predict. Perform. Recover.

The company will also launch new promotional activities:Surgeon - Guided Autono MeThis deliberate spelling emphasizes that the event focuses on a surgeon-centered intelligent surgical system, with only one goal: to give surgeons more autonomy, rather than taking control away from them.

Zimmer Biomet Chief Science, Technology, and Medical Affairs Officer Jonathan Vigdorchik, a Doctor of Medicine, stated: "'Surgeon - Guided Autonomy' reflects the relationship we believe should be established between surgeons and technology. For surgeons, this means that intelligent technology takes on more cognitive and physical tasks, allowing them to focus their professional abilities on decisions that only they can make. For patients, it means that surgeons can concentrate entirely on the patient themselves, with support from intelligent surgical systems designed to assist in decision-making and help execute the surgical plan, and this is true for every case. This is not just about a particular robotic platform. It is our vision to integrate intelligence, robotics, and data throughout the entire nursing process, empowering surgeons rather than replacing them. We believe that the orthopedic industry is moving in this direction, and Zimmer Biomet intends to lead this process."

New Category

The concept of “Surgeon - Guided Autonomy” has revolutionized the traditional relationship between surgeons and operating room technology. It places surgeons back in their rightful position at the center, rather than requiring them to do more around the technology. This vision holds that, within a “surgeon-guided autonomy” framework, intelligent surgical systems should take on more responsibility, translating clinical intentions into actions that span planning, execution, and rehabilitation, while still allowing surgeons to maintain their judgment and control.

According to the definition of “Surgeon - Guided Autonomy” provided by Zimmer Biomet, this technology should:

• Understand the intentions of the surgeon;
• Performs on behalf of the surgeon;
• To allow the surgeon to maintain command and control;
• And to form a learning loop that connects the conditions during surgery with the patient's recovery, so that each case can provide reference for the next plan.

Zimmer Biomet's vision for this category of frameworks:

“Surgeon - Guided Autonomy” is constructed around three interconnected moments in the nursing journey and is connected through a continuous loop:

• Perform— Transform the surgeon's plan into autonomous execution of the established surgical tasks, while continuously monitoring and under the supervision of the surgeon.
• Recover– Independently analyze rehabilitation data to identify patients whose progress deviates from expectations, and provide actionable insights to the nursing team, while also offering information for future surgical planning.

Doctors from the Cleveland Clinic, who are part of the N-token initiative las Piuzzi, stated: "Today, planning, surgery, and rehabilitation often operate in isolation from each other, forcing surgeons to try to connect these aspects themselves. To address these fragmented systems and involve surgeons more closely, Zimmer Biomet created the category ‘Surgeon - Guided Autonomy’, which encourages surgeons to rethink what technology should be involved in the process and what should remain in our hands. ‘Surgeon - Guided Autonomy’ views these stages as a continuous cycle, so that whatever we learn from each rehabilitation session can inform the next planning stage. Surgeons and the medical system no longer have to wait; they can begin to build more closely connected practices right away. Today, I am using many of the foundational components provided by Zimmer Biomet: ROSA Knee with OptimiZe Persona Knee System ZB Edge Analytics and Care Management Platform."

This is just the beginning! For more updates on related discussions, please visit surgeonguided.com.

Editor's Note:

At Booth 608, you can learn about the hip and knee joint product portfolios of Surgeon - Guided AutonoMe, Perform, Recover, as well as Zimmer Biomet throughout the entire weekend. These include ROSA Knee, with, OptimiZe, OrthoGrid HipAI, ZB Edge Analytics, mymobility, Care Management Platform, and Persona IQ The Smart Knee, as well as the Persona, Z1, and G7 systems.

TMINI Miniature Robotic System is a registered trademark of THINK Surgical and Inc.

Persona IQ: The objective kinematic data provided by CSE, CTE and CHIRP System is not intended to support clinical decision-making, nor has it been proven to have any clinical benefits.

About Zimmer Biomet

Zimmer Biomet is a global leader in medical technology, possessing a comprehensive product portfolio aimed at maximizing mobility and improving health. The company seamlessly enhances the patient experience through innovative products and integrated digital and robotics technology suites that leverage data, data analytics, and artificial intelligence.

With over 90 years of trusted leadership and proven professional experience, Zimmer Biomet is capable of providing the highest quality solutions for patients and healthcare providers. The company's tradition continues to thrive today through its culture of continuous evolution and innovation.

For more information about the company's product portfolio, operations in over 25 countries, and sales in more than 100 countries, or to learn about joining the team, please visit www.zimmerbiomet.com. You can also follow the company on LinkedIn ( www.linkedin.com / company / zimmerbiomet ) and X ( www.x.com / zimmerbiomet ).

Forward-looking Statements Warning

This press release contains forward-looking statements as defined by the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding Zimmer Biomet's expectations, plans, prospects, and supply of products and services, including the launch of new products and potential clinical success. These statements are based on management's current beliefs and expectations and are subject to significant risks, uncertainties, and changes in circumstances, and actual results may differ materially from them. For a list of certain risks and uncertainties and descriptions thereof, please refer to the periodic reports submitted by Zimmer Biomet to the U.S. Securities and Exchange Commission (SEC). These factors should not be considered exhaustive and should be read in conjunction with other cautionary statements contained in the documents submitted by Zimmer Biomet to SEC. Forward-looking statements are only valid as of the date they are made, and Zimmer Biomet does not undertake any intention or obligation to update or revise any forward-looking statements due to new information, future events, or other reasons.

Readers are reminded not to rely on these forward-looking statements, as there is no assurance that they will prove to be accurate. This cautionary statement applies to all forward-looking statements contained in this press release.

“Surgeon - Guided AutonoMe” and “Surgeon - Guided Autonomy” describe a category of technology and a vision framework; they are not products. Statements regarding the development of intelligent surgical systems are forward-looking and do not describe any currently available for sale products; no content in this document should be interpreted as promotion of unapproved products or indications. Please verify the product approval status in each country and refer to the specific product instruction manuals.